| scholarly article | Q13442814 |
| P356 | DOI | 10.1124/MOL.58.2.312 |
| P698 | PubMed publication ID | 10908298 |
| P2093 | author name string | S Wonnacott | |
| S Kaiser | |||
| P433 | issue | 2 | |
| P304 | page(s) | 312-318 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release | |
| P478 | volume | 58 |
| Q37081416 | A psychobiological framework of the substrates that mediate nicotine use during adolescence |
| Q35035848 | A role for glutamate in subjective response to smoking and its action on inhibitory control |
| Q28265120 | ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders |
| Q58790106 | Acetylcholine Neurotransmitter Receptor Densities in the Striatum of Hemiparkinsonian Rats Following Botulinum Neurotoxin-A Injection |
| Q37725116 | Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. |
| Q52690614 | Alcohol exposure disrupts mu opioid receptor-mediated long-term depression at insular cortex inputs to dorsolateral striatum. |
| Q41151063 | Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a potent and selective antagonist at rat and human native alpha7 nicotinic acetylcholine receptors |
| Q38532889 | Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease |
| Q36797967 | Animal models and treatments for addiction and depression co-morbidity |
| Q36052826 | Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation |
| Q36042479 | Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions |
| Q42453415 | Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release |
| Q37454529 | Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. |
| Q62887568 | Complex Control of Striatal Neurotransmission by Nicotinic Acetylcholine Receptors via Excitatory Inputs onto Medium Spiny Neurons |
| Q44058969 | Decreased cholinergic receptor expression in the striatum: motor function deficit in hypoglycemic and diabetic rats |
| Q33917311 | Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease |
| Q33575152 | Differential effects of presynaptic versus postsynaptic adenosine A2A receptor blockade on Δ9-tetrahydrocannabinol (THC) self-administration in squirrel monkeys. |
| Q33598688 | Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers |
| Q34654483 | Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity |
| Q22251247 | Dopamine release in the basal ganglia |
| Q46402511 | Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release |
| Q50676033 | Effect of varenicline on aspects of inhibitory control in smokers. |
| Q46772851 | Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain |
| Q47319226 | Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens |
| Q34490801 | Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice |
| Q52712570 | Fast synaptic transmission in the goldfish CNS mediated by multiple nicotinic receptors. |
| Q37046788 | Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum. |
| Q34997975 | Glutamate-dopamine crosstalk in the rat prefrontal cortex is modulated by Alpha7 nicotinic receptors and potentiated by PNU-120596. |
| Q40278018 | Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release. |
| Q40633530 | Identification of an alternatively processed nicotinic receptor α7 subunit RNA in mouse brain |
| Q44185954 | Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. |
| Q48507588 | In vivo effects of the anatoxin-a on striatal dopamine release |
| Q48451558 | In vivo neurochemical characterization of anatoxin-a evoked dopamine release from striatum |
| Q42565570 | Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity |
| Q37629259 | Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications |
| Q42500404 | Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? |
| Q90750119 | Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions |
| Q37623378 | Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. |
| Q43686156 | Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. |
| Q58603895 | Local μ-Opioid Receptor Antagonism Blunts Evoked Phasic Dopamine Release in the Nucleus Accumbens of Rats |
| Q91699841 | Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors |
| Q90603824 | More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder |
| Q42676936 | Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice |
| Q41770343 | N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity |
| Q37149023 | Neurochemicals involved in medullary control of common carotid blood flow |
| Q35601652 | Nicotine and Parkinson's disease: implications for therapy |
| Q34995021 | Nicotine and nicotinic receptors; relevance to Parkinson's disease |
| Q46041518 | Nicotine induces sensitization of turning behavior in 6-hydroxydopamine lesioned rats. |
| Q46616192 | Nicotine regulates DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) phosphorylation at multiple sites in neostriatal neurons |
| Q59356931 | Nicotinic Acetylcholine Receptors in HIV: Possible Roles During HAND and Inflammation |
| Q43977389 | Nicotinic acetylcholine receptor-mediated release of [3H]norepinephrine from developing and adult rat hippocampus: direct and indirect mechanisms |
| Q43940157 | Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression. |
| Q34631254 | Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse |
| Q26861923 | Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals |
| Q35097046 | Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats |
| Q37518024 | Nicotinic receptor-based therapeutics and candidates for smoking cessation |
| Q36882136 | Nicotinic receptors as CNS targets for Parkinson's disease |
| Q35215177 | Presynaptic ionotropic receptors controlling and modulating the rules for spike timing-dependent plasticity |
| Q42220091 | Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors |
| Q39448394 | Promoter methylation and tissue-specific transcription of the α7 nicotinic receptor gene, CHRNA7. |
| Q34394190 | Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors |
| Q37329121 | Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid |
| Q36052464 | Regulation of the common carotid arterial blood flow by nicotinic receptors in the medulla of cats |
| Q42713160 | Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum. |
| Q48022291 | Striatal Local Circuitry: A New Framework for Lateral Inhibition. |
| Q26863113 | Striatal cholinergic interneuron regulation and circuit effects |
| Q39414543 | Striatal cholinergic interneurons and Parkinson's disease. |
| Q34524803 | Striatal dopamine neurotransmission: regulation of release and uptake |
| Q28506626 | Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice |
| Q34502468 | Targeting glutamate homeostasis for potential treatment of nicotine dependence |
| Q48147166 | The alpha7-nicotinic receptor contributes to gp120-induced neurotoxicity: implications in HIV-associated neurocognitive disorders. |
| Q46597266 | The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats |
| Q34154675 | The frequency-dependence of the nicotine-induced inhibition of dopamine is controlled by the α7 nicotinic receptor |
| Q52680310 | The striatal cholinergic system in L-dopa-induced dyskinesias. |
| Q36933882 | The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum |
| Q34186299 | The α7 nicotinic receptor agonist ABT-107 decreases L-Dopa-induced dyskinesias in parkinsonian monkeys |
| Q42094999 | The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions |
| Q38274740 | Tris-azaaromatic quaternary ammonium salts: Novel templates as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release |
| Q30404614 | Understanding the role α7 nicotinic receptors play in dopamine efflux in nucleus accumbens |
| Q36936930 | α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats |
| Q35264378 | α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease |
| Q36469995 | α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage |
Search more.